África
Vales Aranguren
Hospital Universitario de Canarias
San Cristóbal de La Laguna, EspañaPublikationen in Zusammenarbeit mit Forschern von Hospital Universitario de Canarias (2)
2024
-
Efficient and safe therapeutic use of paired Cas9-nickases for primary hyperoxaluria type 1
EMBO molecular medicine, Vol. 16, Núm. 1, pp. 112-131
2018
-
CRISPR/Cas9-mediated glycolate oxidase disruption is an efficacious and safe treatment for primary hyperoxaluria type I
Nature Communications, Vol. 9, Núm. 1